MRNA Search Earning | ticker

Login

Moderna Lululemon U.S. PPI Signet Jewelers KB Home JP Morgan Chase U.S. CPI Target Corp. UnitedHealth

Moderna Inc

MRNA

Moderna Inc. declined 20% to $33.72 after the biotech company lowered its 2025 revenue range to between $1.5 billion and $2.5 billion, a decrease of $1 billion from the previous estimate as the company continues its operating costs.

The revised outlook is lower than the previous outlook between $2.5 billion and $3.5 billion issued in September.
Jan 13, 2025

More

Year	Mar	Jun	Sep	Dec	Annual

2023	0.19	-3.62	-9.53	-	-
2022	8.58	5.24	2.53	3.77	20.12
2021	2.84	6.46	7.7	11.29	28.29
2020	-0.35	-0.31	-0.59	-0.71	-1.96
2019	-0.4	-0.41	-0.37	-0.37	-1.55
2018	-1.16	-1.43	-1.32	-	-3.91
2017	0.01	-	0.10	-	0.11
2016	0.05	0.08	0.05	-	0.18
2015	0.04	0.03	0.06	0.02	0.15